HQ Function

Serves as the primary center for research and development, laboratory operations, and corporate administration for Xintela's regenerative medicine and oncology programs.

Notable Features:

Located within Medicon Village, a prominent life science research park offering state-of-the-art laboratories, infrastructure, and a collaborative ecosystem with other biotech companies and research institutions.

Work Culture:

Characterized by a strong scientific focus, innovation, and collaboration. Employees are typically engaged in research, development, and bringing novel therapies to patients, fostering a mission-driven atmosphere.

HQ Significance:

Its location in Medicon Village is highly significant, providing access to a rich ecosystem of life science expertise, advanced research facilities, potential collaborators, and a skilled talent pool, crucial for a biotech company's growth and innovation.

Values Reflected in HQ: The choice of Medicon Village reflects Xintela's commitment to scientific excellence, innovation, and collaboration by being part of a dynamic and supportive life science community.

Location:

While headquartered in Sweden, Xintela's research and development in stem cell therapies and oncology target global health challenges. The company aims to commercialize its products on an international scale and collaborates with research institutions and potential partners worldwide to advance its therapeutic programs. Its subsidiary Targinta's FDA Orphan Drug Designation for TARG9 in glioblastoma underscores its international regulatory engagement.

Street Address:

Scheeletorget 1

City:

Lund

State/Province:

Skåne

Country:

Sweden